ATRX OTC
Adhera Therapeutics Inc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -99.0%
3Y: -99.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.01
Volume84,001
Avg Volume124
Beta873.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid A. Battat
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date1993-12-07
Websiteadherathera.com
8000 Innovation Parkway
Baton Rouge, LA 70820
US
Baton Rouge, LA 70820
US
919 518 3748
About Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinsonâs disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Subhan Zahed | 0 | — | 2021-11-05 | |
| Waerness Trond Kydd | 0 | — | 2021-04-20 | |
| KUCHARCHUK ANDREW AL | 0 | — | 2020-07-07 | |
| Stanley Rhonda L. | 0 | — | 2019-11-01 | |
| Phelan Nancy R. | 0 | — | 2018-10-01 |